# TITAN PHARMACEUTICALS INC: Form D filings

TITAN PHARMACEUTICALS INC, a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2019 and 2022. The latest, on February 7, 2022, reports $1.5 million sold of a $7 million offering to 1 investor.

Find out what TITAN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TITAN%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TITAN%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftitan-pharmaceuticals-inc-910267)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TITAN%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TITAN%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftitan-pharmaceuticals-inc-910267)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 400 OYSTER POINT BLVD, SUITE 505, San Francisco, CA, 94080
- Phone: (650) 244-4990
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 910267

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 7, 2022 | New notice | $7,019,570 | $1,520,669 | $5,498,901 | 1 | Feb 4, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/910267/000110465922012881/0001104659-22-012881-index.htm) |
| Jan 21, 2021 | New notice | $9,673,750 | $9,673,750 | $0 | 7 | Jan 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/910267/000110465921006035/0001104659-21-006035-index.htm) |
| Jan 9, 2020 | New notice | $2,175,000 | $2,175,000 | $0 | 5 | Jan 9, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/910267/000110465920002692/0001104659-20-002692-index.htm) |
| Aug 19, 2019 | New notice | $2,125,512 | $2,125,512 | $0 | 1 | Aug 9, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/910267/000114420419040674/0001144204-19-040674-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Katherine Beebe DeVarney | Executive Officer, Director |  |
| James R. McNab, Jr. | Director |  |
| Marc Rubin | Executive Officer, Director |  |
| Joseph A. Akers | Director |  |
| M. David McFarlane | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Feb 7, 2022](https://specstream.ai/data/form-d/week/2022-02-07) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TITAN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).